Iovance Biotherapeutics Inc (IOVA) Directors and Executive Officers

Officers & Directors

Athena Countouriotis
Director

Frederick G. Vogt
Interim Chief Executive Officer and President

Merrill A. McPeak
Director

Jean-Marc Bellemin
Chief Financial Officer and Treasurer

Iain Dukes
Director

Wendy L. Yarno
Director

Michael Weiser
Director

Wayne Rothbaum
Director

Ryan D. Maynard
Director ,

Iovance Biotherapeutics inc currently has 975 employees.

News about Iovance Biotherapeutics inc Key Personnel

Iovance Biotherapeutics Executes Inducement Grants for Key Executives and Staff to Enhance Innovation Amidst Financial Challenges,

In an effort to bolster innovation and maintain a competitive edge within the biotechnology sector, Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) has announced a series of inducement stock grants aimed at attracting and retaining talent in a challenging market environment. Notably, the company recently approved stock options and restricted stock units for the new Chief Commercial Officer, Daniel Kirby, as well as a larger initiative to benefit non-executive employees.On February 10, 2025, Iovance granted inducement stock options and restricted stock units totaling an aggregate of 305,000 shares to Daniel Kirby. This announcement highlights Iovance s commitment to empower its leadership team as the company nav...